MDT vs ZBH
MDT: Global medical device leader deploying pacemakers, defibrillators, spinal implants, surgical robotics, and diabetes management systems to alleviate pain, restore health, and extend life across 150+ countries. ZBH: A global medical device company focused on musculoskeletal healthcare, including orthopedic implants and advanced surgical technologies.
Side-by-side fundamentals
| Metric | MDT | ZBH | Edge |
|---|---|---|---|
| Price as of 2026-08-06 close | $85.92 | $97.19 | |
| Market cap as of 2026-08-08 | $110.0B | $18.5B | |
| P/E as of 2026-08-08 | 22.77 | 23.32 | MDT lower |
| PEG as of 2026-08-08 | 3.09 | 4.54 | MDT lower |
| Net margin as of 2026-08-08 | +13.2% | +9.5% | MDT higher |
| Gross margin as of 2026-08-08 | +65.3% | +69.9% | ZBH higher |
| Operating margin as of 2026-08-08 | +17.8% | +14.2% | MDT higher |
| ROE as of 2026-08-08 | +9.8% | +6.3% | MDT higher |
| ROA as of 2026-08-08 | +5.2% | +3.5% | MDT higher |
| Debt / equity as of 2026-08-08 | 0.57 | 0.59 | MDT lower |
| Revenue growth (YoY) as of 2026-08-08 | +8.4% | +8.6% | ZBH higher |
| Revenue CAGR (3y) SEC XBRL | +5.2% | +5.9% | ZBH higher |
| Dividend yield as of 2026-08-08 | +3.4% | +1.0% | MDT higher |
| Dividend streak (yrs) SEC XBRL | 5 | 5 | Tie |
| Beta as of 2026-08-08 | 0.56 | 0.48 | |
| 1-year return as of 2026-08-06 close | -3.8% | +6.6% | ZBH higher |
Fundamentals: market data, as of 2026-08-08. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-06.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.